Immunology Market Insights Video

According to Cognitive Market Research, the global Immunology market size was USD 99548.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 12.60% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 39819.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 29864.46 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 22896.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD4977.41 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.0% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 1990 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031.
• The Monoclonal Antibody (mAb) held the highest Immunology market revenue share in 2024.